The results showed that patients in the high CSF-1R expression group had a higher proportion of tumor size, lymph node metastasis, and FIGO (International Federation of Obstetrics and Gynecology) stage than those in the low CSF-1R expression group. The gene discussed is CSF1R; the disease is neoplasm.